Request Demo
Last update 08 Mar 2025
Shanghai Xunyao Biotechnology Co., Ltd.
Last update 08 Mar 2025
Overview
Basic Info
Introduction Shanghai Xunyao Biotechnology Co., Ltd., known as Circulate Biotech, was established by Professor Junling Liu and his research group from the School of Medicine at Shanghai Jiao Tong University. The company's primary focus lies in the development of antibody medications, nucleic acid therapies, and cell-based treatments. It is dedicated to uncovering novel pathogenic mechanisms and pioneering the research and development of innovative pharmaceuticals across various therapeutic areas. |
Tags
Other Diseases
Cardiovascular Diseases
Hemic and Lymphatic Diseases
Antibody
Bispecific antibody
Monoclonal antibody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT06267183
A Phase I, Single-center, Randomized, Double-blind, Single-dose, Dose-ascending, Placebo-controlled Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
CTR20234287
单中心、随机、双盲、单次给药、剂量递增、安慰剂对照设计，评价SV001雾化吸入溶液在中国健康成年受试者中的安全性、耐受性、药代动力学特征和免疫原性的I期临床试验
[Translation] A single-center, randomized, double-blind, single-dose, dose-escalation, placebo-controlled Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and immunogenicity of SV001 nebulized inhalation solution in healthy Chinese adult subjects
100 Clinical Results associated with Shanghai Xunyao Biotechnology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shanghai Xunyao Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Xunyao Biotechnology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 12 Mar 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Phase 1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free